Highlights Pressure BioSciences, Inc.

Equities

PBIO

US74112E2081

Market Closed - OTC Markets Other stock markets 12:58:10 2024-07-03 EDT			5-day change	1st Jan Change
0.1196 ^USD	+1.96%		-5.45%	-63.76%

06-25	Pressure BioSciences, Inc. Partners with Vita-Forte to Commercialize Highly Potent, Multi-Antioxidant, UST Nanoemulsion Oral Spray	CI
06-20	Transcript : Pressure BioSciences, Inc. - Special Call

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Pressure BioSciences, Inc. Partners with Vita-Forte to Commercialize Highly Potent, Multi-Antioxidant, UST Nanoemulsion Oral Spray	06-25	CI
Pressure BioSciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	06-07	CI
Pressure BioSciences, Inc. Completes Relocation into New Manufacturing Facility, Consolidating R&D with Expanded UltraShear Equipment Development and Contract Manufacturing	02-15	CI
Pressure BioSciences, Inc. completed the acquisition of CBH International LLC.	01-21	CI
Pressure BioSciences, Inc. Receives Open Order Agreement from West Coast Manufacturing Partner	01-18	CI
Pressure BioSciences, Inc. entered into a definitive agreement to acquire CBH International LLC.	01-10	CI
Pressure BioSciences' BaroFold Platform Expected to Revolutionize Biopharmaceutical Production with Help from New Computational (AI/ML) Technologies	01-04	CI
Pressure BioSciences, Inc. Announces the Publication of Pivotal Scientific Study in the Critical Field of Food Safety	12-12	CI
Pressure BioSciences and Veterans Service Team Launch UltraShear Best-in-Class Nano-CBD Topical Spray - MMA Champ Cat Zingano Now Official VST Ambassador	12-01	CI
Earnings Flash (PBIO) PRESSURE BIOSCIENCES Reports Q3 Revenue $413,009	11-21	MT
Pressure BioSciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-20	CI
Pressure Biosciences Announces Exclusive Distribution Agreement with Bioscreen Instruments Pvt Ltd	23-10-18	CI
Pressure BioSciences' Partner Veterans Service Team Increases Existing Purchase Order by 10X for Bottles of UltraShear Nano-CBD Topical Spray, Effective Immediately	23-09-22	CI
Earnings Flash (PBIO) PRESSURE BIOSCIENCES Posts Q2 Revenue $511,800	23-08-22	MT
Pressure BioSciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-21	CI
Pressure BioSciences, Inc. Announces UltraShear Nano-CBD Roll-Out Program Enters Rapid Expansion Phase of Distribution and Partnering	23-07-17	CI
Pressure BioSciences, Inc. Announces UltraShear Processed Nano-CBD Topical Spray Distribution Agreement with Premier CA Cannabis Partner Creme de Canna	23-07-10	CI
Pressure BioSciences, Inc. Announces Agreement with Somalab International LLC for Development & Distribution of UltraShear-Enabled Nanoemulsified Health and Wellness Products	23-07-05	CI
Pressure Biosciences, Inc. Announces Results from Third Round of Consumer Focus Group Testing of THC Nanoemulsion Oral Spray	23-06-27	CI
Pressure BioSciences, Inc. Partners with Veterans Service Team to Offer Exclusive Access for VST Members to a Unique, Custom-Made, UltraShear Nano-CBD & Other Products	23-06-13	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Pressure BioSciences, Inc.

Equities

PBIO

US74112E2081

Highlights

Filters